Exicure (XCUR) Times Interest Earned (2016 - 2025)
Exicure (XCUR) reported Times Interest Earned of -$2256.0 for Q4 2025, down 952.57% quarter-over-quarter from -$214.33 in Q3 2024.
Exicure (XCUR) Times Interest Earned (2016 - 2025) Analysis & Trends
Exicure has reported Times Interest Earned for 9 years, with the latest figure at -$2256.0 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned changed N/A year-over-year to -$2256.0; the trailing twelve-month figure through Mar 2026 stood at -$8796.0 (down 1768.62% YoY), and the FY2025 full-year result was -$4233.0, down 522.91% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$2256.0, down from -$214.33 in the prior quarter.
- The five-year high for Times Interest Earned was -$13.0 in Q1 2022, with the low at -$2256.0 in Q4 2025.
- Historically, Times Interest Earned has averaged -$354.51 across 4 years, with a median of -$43.2 in 2021.
- The largest YoY upside for Times Interest Earned was 84.98% in 2021 against a maximum downside of 812.48% in 2021.
- Exicure's Times Interest Earned stood at -$35.67 in 2021, then soared by 63.55% to -$13.0 in 2022, then plunged by 1548.29% to -$214.33 in 2024, then slumped by 952.57% to -$2256.0 in 2025.
- The last three Times Interest Earned figures came in at -$2256.0 (Q4 2025), -$214.33 (Q3 2024), and -$205.83 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,256.00 |
| Sep 30, 2024 | -214.33 |
| Jun 30, 2024 | -205.83 |
| Mar 31, 2022 | -13.00 |
| Dec 31, 2021 | -35.67 |
| Sep 30, 2021 | -50.73 |
| Jun 30, 2021 | -30.80 |
| Mar 31, 2021 | -29.72 |
| Dec 31, 2020 | -29.81 |
| Sep 30, 2020 | -337.78 |
| Mar 31, 2020 | 4.17 |
| Dec 31, 2019 | -51.31 |
| Sep 30, 2019 | -29.29 |
| Jun 30, 2019 | -24.55 |
| Mar 31, 2019 | -30.48 |
| Dec 31, 2018 | -27.82 |
| Sep 30, 2018 | -34.49 |
| Jun 30, 2018 | -34.96 |
| Mar 31, 2018 | -32.82 |
| Dec 31, 2017 | -18.52 |